Drug Pipeline

LN-145 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
2
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07288073 TIL Therapy in cSCC and MCC Cutaneous Squamous Cell Carcinoma Recruiting
NCT04614103 Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Recruiting
NCT07560111 A Phase II Study of GC101 in NSCLC Non Small Cell Lung Cancer Not Yet Recruiting
NCT03449108 LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer… Bone Sarcoma Active, Not Recruiting
Sponsors Running LN-145 Trials
M.D. Anderson Cancer Center (1) Iovance Biotherapeutics, Inc. (1) Karam Khaddour, MD, MS (1) Shanghai Juncell Therapeutics (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Breast Cancer (1) Triple-Negative Breast Cancer (1) Ovarian Cancer (1) Sarcoma (1)
Get alerts when LN-145 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free